Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $19.7 (market cap $7.77B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.63 (market cap $2.27B). The key difference: Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF is far larger — about 3.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| PDBC | SLS | |
|---|---|---|
Market Cap | $7.77B | $2.27B |
Volume | 6,100,303 | 4,179,659 |
52-Week High | $20.10 | $15.46 |
52-Week Low | $13.16 | $1.39 |
Typical Hold Time | 56 Days | — |
Sector | — | Health |
Enterprise Value | — | $2.14B |
Signals from Pluang's Aura AI — not financial advice
PDBC (Invesco Optimum Yield Diversified Commodity Strategy ETF) trades at $19.68, up 1.39% with strong bullish momentum. The ETF has delivered exceptional performance, rising 45.66% year-to-date driven by energy and agricultural gains amid geopolitical turmoil. Technical indicators show bullish moving averages but neutral oscillators, with RSI at 72.89 suggesting potential overbought conditions. Recent institutional activity shows significant position increases despite a 215% surge in short interest.
The outlook remains positive given strong commodity trends and defensive positioning appeal, though elevated short interest and geopolitical risks warrant caution. Commodity exposure provides inflation hedge benefits, but price volatility and concentrated sector risks require careful monitoring for investors seeking diversified commodity exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →